<DOC>
	<DOCNO>NCT01340482</DOCNO>
	<brief_summary>The primary purpose study assess safety efficacy repeat subcutaneous ( SC ) injection KRN23 adult subject X-Linked Hypophosphatemia ( XLH ) . A Bone Substudy evaluate effect single-blind KRN23 versus Placebo bone mineral density bone quality .</brief_summary>
	<brief_title>A Repeated Study KRN23 Adults With X-Linked Hypophosphatemia</brief_title>
	<detailed_description />
	<mesh_term>Familial Hypophosphatemic Rickets</mesh_term>
	<mesh_term>Hypophosphatemia</mesh_term>
	<criteria>Main 1 . 18 year old 2 . Clinical diagnosis XLH 3 . TmP/GFR &lt; 2.0 mg/dL 4 . GFR â‰¥60 mL/min 5 . Corrected Ca &lt; 10.8 mg/dL 6 . A willingness utilize adequate contraception become pregnant [ partner ( ) become pregnant ] study 7 . Additional inclusion criterion apply Main 1 . Have sign active infectious disease infection require treatment antibiotic within 3weeks Screening 2 . History known immunodeficiency 3 . Pregnant lactate female subject female plan become pregnant study 4 . Receipt live ( attenuate ) vaccine ( except influenza vaccine ) within 3months Screening , and/or study 5 . Use pharmacologic vitamin D metabolite analog , phosphate , calcimimetics , ingestion aluminum hydroxide antacid within 10days prior Screening and/or dose 6 . Use supplement contain phosphate , calcium and/or vitamin D within 10days prior Screening and/or dose 7 . Condition could present concern either subject 's safety difficulty data interpretation 8 . Additional exclusion criterion apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>XLH</keyword>
</DOC>